3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid and dronabinol

3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid has been researched along with dronabinol in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hasegawa, T; Kameyama, T; Kinoshita, H; Nabeshima, T; Yamamoto, I1

Other Studies

1 other study(ies) available for 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid and dronabinol

ArticleYear
Competitive NMDA antagonists enhance the catalepsy induced by delta 9-tetrahydrocannabinol in mice.
    Neuroscience letters, 1994, Jun-06, Volume: 174, Issue:1

    Topics: 2-Amino-5-phosphonovalerate; 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Amantadine; Amino Acids; Animals; Anticonvulsants; Catalepsy; Dizocilpine Maleate; Dopamine Agonists; Dose-Response Relationship, Drug; Dronabinol; Drug Synergism; Ergolines; Haloperidol; Male; Mice; Mice, Inbred Strains; Motor Activity; Piperazines; Quinpirole; Receptors, N-Methyl-D-Aspartate; Scopolamine

1994